PW PeptideWars Evidence league

Growth hormone secretagogues

Sermorelin

A GHRH analog historically studied for growth hormone deficiency testing and pediatric growth contexts.

GHRH 1-29Growth hormone-releasing hormone analog

Concise answer

What is Sermorelin?

Sermorelin is a GHRH analog with older clinical literature in growth hormone deficiency contexts. It should not be treated as proven anti-aging therapy.

Definition

What It Is

Sermorelin is a 29-amino-acid analog of human growth hormone-releasing hormone that stimulates the pituitary to release growth hormone in responsive individuals.

Status

Legal and Regulatory Notes

  • FDA: PeptideWars does not classify sermorelin as a currently marketed FDA-approved anti-aging medication.
  • Research: Older clinical literature supports diagnostic and growth-deficiency contexts, not broad wellness or longevity claims.
  • Sport: GHRH analogs and growth hormone releasing factors are high-risk under anti-doping rules.

Research map

How Sermorelin Is Being Studied

Growth hormone stimulation testingIdiopathic growth hormone deficiency in childrenComparison with somatropin and other provocative testsOff-label wellness claims and anti-doping concerns

People

Human Research

Older reviews describe diagnostic use and limited treatment data in children with idiopathic growth hormone deficiency. Adult anti-aging claims are a different and less-supported question.

Models

Animal and Cell Research

Mechanistic animal work is less central than the older clinical diagnostic literature for sermorelin.

Safety

Known Risks and Side Effects

  • Hormone-axis adverse effects require clinician monitoring
  • Not a shortcut around diagnosis of growth hormone deficiency
  • Potential anti-doping issues
  • Quality and legal uncertainty when obtained outside regulated care

Compliance

Interpretation Guardrails

  • Do not confuse endocrine testing history with consumer anti-aging proof.
  • No dosing or administration instructions are provided.
  • Talk to a licensed clinician for growth, pituitary, fatigue, or hormone concerns.

Internal links

Related Battles and Profiles

Battle Sermorelin vs Ipamorelin A GHRH analog with older clinical literature versus a selective GH secretagogue with limited human pharmacology data. Profile Ipamorelin A selective growth hormone secretagogue studied in early human pharmacology and gastrointestinal motility contexts. Profile CJC-1295 An investigational long-acting GHRH analog studied for growth hormone and IGF-1 signaling. Profile Tesamorelin An FDA-approved GHRH analog product for a specific HIV-associated lipodystrophy indication. Guide Growth Hormone Secretagogues CJC-1295, ipamorelin, sermorelin, and tesamorelin compared by mechanism, evidence, and regulatory status.
FAQ

Common Questions

Is sermorelin an anti-aging peptide?

PeptideWars does not classify sermorelin as proven anti-aging therapy. Its stronger literature is in growth hormone testing and selected deficiency contexts.

How does sermorelin differ from ipamorelin?

Sermorelin is a GHRH analog. Ipamorelin acts through growth hormone secretagogue pathways. Their mechanisms and evidence bases differ.

Should sermorelin be used without testing?

Hormone-related decisions should involve appropriate clinical evaluation by a licensed clinician.

Sources

Citations and Official References

  1. Sermorelin: A Review of Its Use in the Diagnosis and Treatment of Children with Idiopathic Growth Hormone Deficiency PubMed
  2. The Prohibited List WADA

Editorial Review

Written by the PeptideWars Editorial Team. Medical reviewer placeholder: licensed clinician review should be completed before production launch. Last updated May 6, 2026.